Minimally Invasive Surgical Instruments Market (By Device: Handheld Instruments, Inflation Devices, Surgical Scope, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring and Visualization Devices; By Application: Cardiac, Gastrointestinal, Orthopedic, Vascular, Gynecological, Urological, Thoracic, Cosmetic, Dental, Others; By End Use) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2022 - 2030


The global minimally invasive surgical instruments market size was estimated at US$ 27.71 billion in 2021 and it is expected to hit US$ 70 billion by 2030, poised to grow at a CAGR of 10.84% from 2022 to 2030.

Minimally Invasive Surgical Instruments Market Size 2021 to 2030

Growth Factors

Due to benefits of minimally invasive surgical procedures such as fewer serious operative and post operative problems and quicker recovery times are driving the demand for minimally invasive surgical instruments in the global market. In addition, the growing prevalence of chronic disorders is also driving the growth of the global minimally invasive surgical instruments market. As per the World Health Organization (WHO) statistics report for 2021, non-communicable disorders often known as chronic disorders kill around 41 million people each year, accounting for roughly 71% of all deaths worldwide. According to the same source, non-communicable disorders claim the lives of nearly 15 million people aged 30 to 69 years old every year around the globe. Thus, the rising burden of non-communicable diseases is driving the demand for minimally invasive surgical operations. This is directly impacting the expansion of global minimally invasive surgical instruments market over the forecast period.

The impact of the coronavirus outbreak on the growth of global minimally invasive surgical instruments market was quite negative. This is attributed to the supply chain disruptions and trade restrictions. In addition, the hospitals visits have been lowered in number as compared to previous year. Thus, the growing number of vaccinations had negative outlook on the expansion of global minimally invasive surgical instruments market.

The major market players are adopting marketing strategies for the development of global minimally invasive surgical instruments market. The key strategies such as new product launch, mergers, collaborations, and acquisitions are creating market position for market players in global minimally invasive surgical instruments market. For example, Fujifilm Medical Systems USA Inc. introduced its ELUXEO surgical system in July 2020, which combines the company’s endoscopic and minimally invasive surgeries and allows surgeons to perform all type of endoscopic surgeries from a single component with improved visualization.

The growth of global minimally invasive surgical instruments market is attributed to the growing research and development initiatives for the launch of new minimally invasive surgical instruments in the global market. In addition, the government of developed regions is also investing in the development of minimally invasive surgical instruments. All of these aforementioned factors are boosting the growth of the global minimally invasive surgical instruments market.

Report Scope of the Minimally Invasive Surgical Instruments Market

Report Coverage Details
Market Size by 2030 USD 70 Billion
Growth Rate from 2022 to 2030

CAGR of 10.84%

North America Market Share in 2021 44%
Orthopedic Segment Hit The Revenue Share in 2021 25%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Device, Application, End Use, Geography
Companies Mentioned

The Johns Hopkins Hospital, Apollo Hospitals Enterprise Ltd., The General Hospital Corporation, Bedfordshire Hospitals, Stanford Healthcare, Circle Health Ltd., Singapore General Hospital Ltd., Manipal Health Enterprises Pvt. Ltd, Mount Elizabeth Hospital, King Fahd Medical City


Device Insights

The handheld instruments segment accounted largest revenue share in 2021. The handheld instruments segment is growing due to technological developments especially due to adoption of robotics. These minimally invasive surgical instruments are cost effective when compared to other types of minimally invasive surgical instruments. In addition, handheld instruments are easy to operate. All of these aforementioned factors are driving the growth of the segment.

The electrosurgical devices segment is expected to witness strong growth during forecast period. Due to rising frequency of chronic disorders, the ageing population, and the rise in the number of minimally invasive surgical processes, the electrosurgical devices segment is predicted to grow fast throughout the projected period. The demand for cosmetic operations is growing and one key driver driving demand and acceptance of electrosurgical devices in the global market is the rising use of electrosurgical devices in minimally invasive cosmetic surgeries.

Application Insights

The orthopedic segment dominated the market in 2021 with 25% revenue share. The orthopedic minimally invasive surgical processes are quite less risky as compared to traditional surgical methods. As a result, minimally invasive surgical instruments are used in critical orthopedic operations. Due to these factors, minimally invasive surgical instruments are highly adopted by surgeons and orthopedic surgeons.

The cardiac surgery segment is projected to hit strong growth from 2022 to 2030. The minimally invasive operations have a number of advantages over traditional surgeries including less pain and blood loss. In addition, the growing prevalence of cardiovascular disorders is considered as key factor driving the demand for minimally invasive surgical instruments for cardiac surgery.

End Use Insights

The hospital segment accounted revenue share of around 67% in 2021. The market for minimally invasive surgical instruments is expanding due to growing number of hospitals globally. Moreover, the government all around the globe is taking efforts for the development of healthcare facilities. In addition, the rising prevalence of chronic disorders are also contributing towards the growth of the segment.

Minimally Invasive Surgical Instruments Market Share, By End Use 2021 (%)

The ambulatory surgical centers segment is expected to hit remarkable growth during the forecast period. The growing number of ambulatory surgical centers is driving the growth of global minimally invasive surgical instruments market. As per the government records, there are 5,500 ambulatory surgical centers in the U.S. The ambulatory surgical centers are considered as cost effective option as compared to hospitals. The favorable reimbursement policies is driving the adoption of minimally invasive surgical instruments in ambulatory surgical centers on a large scale.

Region Insights

North America led the market in 2021 with revenue share of 44%. The minimally invasive surgical instruments market in this region is expanding due to the growing prevalence of various kind of disorders. Heart disease is the biggest cause of mortality in the U.S. as per an updated report published by the Centers for Disease Control and Prevention in September 2021. About 18.2 million American adults aged 20 and above have coronary artery disease and approximately 360,900 people died from coronary heart disorder in 2019. In addition, adoption of innovative technologies is also driving the growth of minimally invasive surgical instruments market in North America region.

Minimally Invasive Surgical Instruments Market Share, By Region, 2021 (%)

Asia-Pacific, on the other hand, is expected to develop at the fastest rate during the forecast period. China and Japan dominate the minimally invasive surgical instruments market in Asia-Pacific region. The factors such as rapid urbanization, growing geriatric population, and growing trend of medical tourism are boosting the growth of minimally invasive surgical instruments market in this region. In addition, the increase in healthcare expenditure is paving way for the expansion of Asia-Pacific minimally invasive surgical instruments market.

Key Developments

  • Johnson & Johnson introduced the ECHELON+Stapler in March 2021.
  • Ambu Inc. gained Health Canada certification for aScope 4 Cysto, a single use endoscopes platform for urology in April 2021.
  • Titan Spine was bought by Medtronic PLC in June 2019. Medtronic’s position as a worldwide leader in procedural solutions for spine surgery was bolstered by this acquisition. 

Some of the prominent players in the global minimally invasive surgical instruments market include:

  • The Johns Hopkins Hospital
  • Apollo Hospitals Enterprise Ltd.
  • The General Hospital Corporation
  • Bedfordshire Hospitals
  • Stanford Healthcare
  • Circle Health Ltd.
  • Singapore General Hospital Ltd.
  • Manipal Health Enterprises Pvt. Ltd
  • Mount Elizabeth Hospital
  • King Fahd Medical City 

Segments Covered in the Report

(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)

By Device

  • Handheld Instruments
    • Graspers
    • Retractors/Elevators
    • Suturing Instruments
    • Dilators
    • Other
  • Inflation Devices
    • Balloons
    • Balloon Inflation Devices
  • Surgical Scope
    • Laparoscopes
    • Urology Endoscopes
    • Arthroscopes
    • Neuroendoscopes
    • Other
  • Cutter Instruments
    • Trocars
    • Other Cutting Instruments
  • Guiding Devices
    • Guiding Catheters
    • Guidewires
  • Electrosurgical Devices
    • Electrosurgical Instruments
    • Electrocautery Device
  • Auxiliary Devices
  • Monitoring and Visualization Devices

By Application

  • Cardiac
  • Gastrointestinal
  • Orthopedic
  • Vascular
  • Gynecological
  • Urological
  • Thoracic
  • Cosmetic
  • Dental
  • Others

By End Use

  • Hospitals
  • Ambulatory Surgical Centers

 By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of minimally invasive surgical instruments market?
The global minimally invasive surgical instruments market size was reached at US$ 27.71 billion in 2021 and it is anticipated to rake around US$ 70 billion by 2030.
The global minimally invasive surgical instruments market is expected to drive growth at a CAGR of 10.84% during the forecast period 2022 to 2030.
The major players operating in the minimally invasive surgical instruments market are The Johns Hopkins Hospital, Apollo Hospitals Enterprise Ltd., The General Hospital Corporation, Bedfordshire Hospitals, Stanford Healthcare, Circle Health Ltd., Singapore General Hospital Ltd., Manipal Health Enterprises Pvt. Ltd, Mount Elizabeth Hospital, King Fahd Medical City
The growing prevalence of chronic disorders is also driving the growth of the global minimally invasive surgical instruments market.
The North America region is estimated to lead the minimally invasive surgical instruments market during the forecast period.

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample